Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 34 | $5,452,697 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Mar 2025 17:49 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 19 Mar 2025 | Sale | 12,500 | 20.606 | 257,575 | I |
| 22 Oct 2024 16:22 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 18 Oct 2024 | Sale | 847 | 30.003 | 25,413 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 08 Oct 2024 | Sale | 13,167 | 27.9618 | 368,173 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 08 Oct 2024 | Sale | 100 | 28.51 | 2,851 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 09 Oct 2024 | Sale | 34,289 | 28.1199 | 964,203 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 09 Oct 2024 | Sale | 3,589 | 28.5199 | 102,358 | I |
| 08 Oct 2024 18:58 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 04 Oct 2024 | Sale | 7,522 | 27.5109 | 206,937 | I |
| 08 Oct 2024 18:58 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 07 Oct 2024 | Sale | 2,707 | 27.6051 | 74,727 | I |
| 03 Oct 2024 18:47 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Oct 2024 | Sale | 527 | 27.5372 | 14,512 | I |
| 03 Sep 2024 17:43 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Aug 2024 | Sale | 50 | 23.08 | 1,154 | I |
| 03 Sep 2024 17:43 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Aug 2024 | Sale | 11,950 | 22.4843 | 268,687 | I |
| 02 Aug 2024 19:26 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 31 Jul 2024 | Sale | 3,099 | 27.5571 | 85,399 | I |
| 31 Jul 2024 19:33 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Jul 2024 | Sale | 203 | 27.4333 | 5,569 | I |
| 31 Jul 2024 19:33 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Jul 2024 | Sale | 11,797 | 26.6855 | 314,809 | I |
| 03 Jul 2024 16:31 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Jul 2024 | Sale | 12,000 | 22.8947 | 274,736 | I |
| 31 May 2024 16:05 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 May 2024 | Sale | 2,123 | 22.5212 | 47,813 | D |
| 31 May 2024 16:05 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 May 2024 | Sale | 9,877 | 21.564 | 212,988 | D |
| 01 May 2024 19:04 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Apr 2024 | Sale | 1,013 | 18.4823 | 18,723 | D |
| 01 May 2024 19:04 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Apr 2024 | Sale | 10,987 | 17.8634 | 196,265 | D |
| 15 Apr 2024 19:06 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 11 Apr 2024 | Sale | 30,000 | 25.0444 | 751,332 | D |
| 03 Apr 2024 21:30 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Apr 2024 | Sale | 71 | 19.3578 | 1,374 | D |
| 03 Apr 2024 21:30 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Apr 2024 | Sale | 9,577 | 18.8038 | 180,084 | D |
| 03 Apr 2024 21:30 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Apr 2024 | Sale | 2,352 | 17.7242 | 41,687 | D |
| 04 Mar 2024 17:55 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Feb 2024 | Sale | 1,805 | 17.0938 | 30,854 | D |
| 04 Mar 2024 17:55 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Feb 2024 | Sale | 10,195 | 16.2974 | 166,152 | D |
| 31 Jan 2024 21:22 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Jan 2024 | Sale | 12,000 | 15.8547 | 190,256 | D |
| 03 Jan 2024 19:01 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 29 Dec 2023 | Sale | 2,849 | 14.7818 | 42,113 | D |
| 03 Jan 2024 19:01 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 29 Dec 2023 | Sale | 9,151 | 14.1261 | 129,268 | D |
| 26 Dec 2023 19:32 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 22 Dec 2023 | Sale | 6,546 | 13.066 | 85,530 | D |
| 26 Dec 2023 19:32 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 21 Dec 2023 | Sale | 20 | 13 | 260 | D |
| 21 Dec 2023 16:29 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 20 Dec 2023 | Sale | 8,688 | 13.0117 | 113,046 | D |
| 21 Dec 2023 16:29 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 19 Dec 2023 | Sale | 200 | 13 | 2,600 | D |
| 06 Nov 2023 16:43 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 03 Nov 2023 | Sale | 8,546 | 13.0764 | 111,751 | D |
| 03 Oct 2023 19:40 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | Chief Scientific Officer | 29 Sep 2023 | Sale | 12,000 | 13.6248 | 163,498 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)